Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection
Eric A Klein1, Timothy R Church2, Christina A Clarke1
1GRAIL, Inc., Menlo Park, California.
Abstract:
Multi-cancer early detection (MCED) tests may detect a broad spectrum of cancer types, including uncommon types that lack recommended screening. After a cancer signal is detected by an MCED test, some diagnostic process must definitively confirm the patient's cancer status. A commercially available blood-based MCED test detects a cancer signal and then predicts an anatomic location, a cancer signal origin (CSO), to guide the diagnostic process. We extended a preexisting model for MCED cancer screening, adding predicted CSO categories and a simple model of the diagnostic chain. We then predicted outcomes of the diagnostic chain for each predicted CSO and in populations with differing clinical risk factors. Typical positive predictive values were>40%, and using a minimal sufficient level of positive predictive value (>7%), (i) diagnostic workup based on any CSO was generally warranted, and (ii) continued workup for cancers in locations other than the CSO was justifiable. The benefit of prediction-directed workups was also observed via estimated clinical utility metrics, such as lives saved per diagnostic test, and remained applicable in populations with varying cancer risk, such as lung cancer prediction-directed workups in never-smokers. CSO predictions may enable most true-positive cases to be resolved by short and efficient diagnostic processes. The model predicted a large enough conditional benefit to warrant diagnostic workup based on any CSO prediction from an MCED test, assuming late-stage reduction by MCED leads to mortality reduction, which remains to be demonstrated.
Significance:
MCED tests may detect a signal from many cancers. Predicting an anatomic location from which the cancer signal may originate allows effective, usual diagnostic workup. In this study, we show that these predictions are beneficial to physicians choosing a diagnostic path, even for uncommon cancer types and among populations with differing cancer risks.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancers Originate from Somatic Mutations in a Single Cell